TribLIVE

| Opinion/The Review


Pittsburgh Tuesday takes

About The Tribune-Review
The Tribune-Review can be reached via e-mail or at 412-321-6460.
Contact Us | Video | RSS | Mobile


By Tribune-Review

Published: Monday, December 3, 2012, 8:51 p.m.
Updated: Tuesday, February 19, 2013

Charlie's day: Things couldn't have gone much better for Charlie Batch on Sunday. The third-string (though journeyman) quarterback, three days shy of his 38th birthday, came off a lousy performance against Cleveland to lead the Steelers to an upset victory in Baltimore over the archrival Ravens. It was a stellar performance from a stellar Steeler that keeps Pittsburgh, now 7-5, solidly in the playoff picture.

Trauma central: Things couldn't be much worse for West Penn Allegheny Health System. Its debt is junk, it's most assuredly headed for bankruptcy and, now, the Securities and Exchange Commission appears ready to sanction the hospital system for bad old-fashioned book cooking. West Penn Allegheny admitted to inflating revenues by, oh, a measly $73 million a few years back. And the smiles grow wider over at UPMC.

Worm can: Washington County lawyer David DiCarlo, a Democrat, is suing 11 people — Ronald Levy and 10 unnamed others — over a website's claims that he says defamed him, costing him a close race for county district attorney last year. Republican Eugene Vittone defeated Mr. DiCarlo by 112 votes. Mr. Vittone says he had no connection to the website. But should DiCarlo prevail, it could change the face of political advertising. After all, the first casualty of campaigns usually is the truth.

Most Popular Editorials

  1. Medicaid expansion: Corbett’s push-back
  2. After the primary: Leaders needed
  3. Saturday essay: Passages
  4. Step up!
  5. Shooting blanks
  6. Sunday pops
  7. The Box
  8. An American outrage: The IRS attacks conservatives
  9. ObamaCare lies: Shocking truths
  10. Primary 2013: We recommend ...
  11. Pittsburgh Tuesday takes
You must be signed in to add comments

To comment, click the Sign in or sign up at the very top of this page.

There are currently no comments for this story.
Subscribe today! Click here for our subscription offers.